Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In particular, non-random occurrence was revealed for SERPINA1 c.1096G > A (alpha-1 antitrypsin deficiency), C8B c.1282C > T and c.1653G > A (complement component 8B deficiency), ATP7B c.3207C > A (Wilson disease), PROP1 c.301_302delAG (combined pituitary hormone deficiency), CYP21A2 c.844G > T (non-classical form of adrenogenital syndrome), EYS c.1155T > A (retinitis pigmentosa), HADHA c.1528G > C (LCHAD deficiency), SCO2 c.418G > A (cytochrome c oxidase deficiency), OTOA c.2359G > T (sensorineural deafness), C2 c.839_866del (complement component 2 deficiency), ACADVL c.848T > C (VLCAD deficiency), TGM5 c.337G > T (acral peeling skin syndrome) and VWF c.2561 G > A (von Willebrand disease, type 2N).
|
31028847 |
2019 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Patient fibroblasts showed reduced levels of SCO2, decreased copper levels and COX deficiency.
|
29351582 |
2018 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCO2 are among the most common causes of COX deficiency, resulting in reduced mitochondrial oxidative ATP production capacity, often leading to hypertrophic cardiomyopathy (HCM).
|
29193756 |
2018 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
Biomarker
|
disease |
BEFREE |
Remarkably, apoptosis is enhanced in the muscle and liver of Sco2 knock-out mice, clearly suggesting that cell death is a key feature of the COX deficiencies produced by mutations in Sco genes in humans.
|
25792727 |
2015 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
Biomarker
|
disease |
BEFREE |
Mutations in genes for the assembly factors SURF1 and SCO2 are prevalent in children with COX deficiency in the Slavonic population.
|
22592081 |
2012 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Copper and bezafibrate cooperate to rescue cytochrome c oxidase deficiency in cells of patients with SCO2 mutations.
|
22515166 |
2012 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
Biomarker
|
disease |
MGD |
Contrariwise, treatment with the AMPK agonist AICAR led to partial correction of COX deficiency in all three models, and, importantly, significant motor improvement up to normal in the Sco2(KO/KI) mouse.
|
21723506 |
2011 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
Biomarker
|
disease |
MGD |
Analysis of mouse models of cytochrome c oxidase deficiency owing to mutations in Sco2.
|
19837698 |
2010 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in both SCO1 and SCO2 are associated with distinct clinical phenotypes as well as tissue-specific COX deficiency, but the reason for such tissue specificity is unknown.
|
20864674 |
2010 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SCO2 gene [SCO cytochrome oxidase deficient homolog 2 (yeast)] causing cytochrome c oxidase deficiency have been reported in at least in 26 patients with fatal infantile cardioencephalomyopathy.
|
20159436 |
2010 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Structural analysis of tissues affected by cytochrome C oxidase deficiency due to mutations in the SCO2 gene.
|
18254779 |
2008 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Marked prevalence of two nuclear DNA mutations (845-846delCT in the SURF1 gene and 1541G>A in the SCO2 gene) associated with COX deficiency in a Slavonic population suggests the existence of regional differences in the genetic basis of COX deficiency.
|
16326995 |
2006 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
Biomarker
|
disease |
CTD_human |
Marked prevalence of two nuclear DNA mutations (845-846delCT in the SURF1 gene and 1541G>A in the SCO2 gene) associated with COX deficiency in a Slavonic population suggests the existence of regional differences in the genetic basis of COX deficiency.
|
16326995 |
2006 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCO2 have been associated with severe COX deficiency and early-onset fatal infantile hypertrophic cardiomyopathy, encephalopathy, and neurogenic muscle atrophy.
|
15210538 |
2004 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The accompanying paper by Zeman and co-workers reports that mutations in SCO2 are common in infantile COX deficiency and are associated with a very poor prognosis.
|
15499941 |
2004 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
SCO2 mutations should be screened in suspected SMA cases with normal smn mutation analysis and any one of; cardiomyopathy, lactic acidosis, or COX deficiency in muscle.
|
14994243 |
2004 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In 26 children with isolated COX deficiency, we studied mutations in the SCO2 gene, which is involved in the copper transport into the inner mitochondrial membrane, and we analysed the clinical and biochemical consequences of SCO2 mutations.
|
15499950 |
2004 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
This study establishes COX15 as an additional cause, along with SCO2, of fatal infantile, hypertrophic cardiomyopathy associated with isolated COX deficiency.
|
12474143 |
2003 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our data demonstrate that the COX deficiency observed in fibroblasts, myoblasts and myotubes from patients with SCO2 mutations can be restored to almost normal levels by the addition of CuCl(2) to the growth medium.
|
11931660 |
2002 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease.
|
12020273 |
2002 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCO2 have been described in patients with severe COX deficiency and early onset fatal infantile hypertrophic cardioencephalomyopathy.
|
11673586 |
2001 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts.
|
11751685 |
2001 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts.
|
11751685 |
2001 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency.
|
10749987 |
2000 |
Cytochrome-c Oxidase Deficiency
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In addition, biochemical and morphological studies showed that the COX deficiency was more severe in patients with SCO2 mutations.
|
10805329 |
2000 |